Inventor
KASHIWAGI HIROTAKA
JP17 patents
⚠️ This page may combine multiple inventors who share the name “KASHIWAGI HIROTAKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
13 patentsUS10858356B2Dec 8, 2020
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD18 citations93
US11814381B2Nov 14, 2023
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD3 citations83
US7026491B2Apr 11, 2006
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD6 citations72
US12410168B2Sep 9, 2025
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US12331049B2Jun 17, 2025
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US12331050B2Jun 17, 2025
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD0 citations61
USRE50455EJun 10, 2025
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US12187724B2Jan 7, 2025
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US7994318B2Aug 9, 2011
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7872142B2Jan 18, 2011
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7709664B2May 4, 2010
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US9499553B2Nov 22, 2016
Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same
CHUGAI PHARMACEUTICAL CO LTD1 citations46
US7935688B2May 3, 2011
Vitamin D-like compound
CHUGAI PHARMACEUTICAL CO LTD0 citations39